The 'me toos' offer real benefits to many
In most other industries, "me-tooism" is called "competition," ordinarily the object of applause rather than condemnation

Article Highlights

  • In most other industries, "me-tooism" is called "competition," ordinarily the object of applause rather than condemnation.

    Tweet This

Henry Miller is too modest in his excellent criticism of those who argue that second and third drugs in a class waste resources and yield little clinical benefit ("Critics of 'Me-Too Drugs' Need to Take a Chill Pill," op-ed, Jan.2).

In most other industries, "me-tooism" is called "competition," ordinarily the object of applause rather than condemnation. More broadly, the me-too argument is statist, based upon an assumption that patients and their physicians are incapable of evaluating the relevant trade-offs, which should be left to bureaucrats, officials and "experts." The blindness of the latter group is illustrated by the development of esomeprazole (Nexium) after use of omeprazole (Prilosec) became widespread. Omeprazole was problematic for patients lacking a key liver enzyme, and the newer drug proved superior for them.

What bureaucracy has incentives to undertake such a pursuit? Sadly, the implicit price controls of the Affordable Care Act will reduce these incentives even for the private sector.

Benjamin Zycher

American Enterprise Institute

Washington

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Benjamin
Zycher

What's new on AEI

Poverty in America—and What to Do About It
image GDP for second quarter: Strong headline, weak innards
image Paul Ryan and the emerging conservative reform agenda in higher education
image Democrats' impeachment fixation
AEI on Facebook
Events Calendar
  • 28
    MON
  • 29
    TUE
  • 30
    WED
  • 31
    THU
  • 01
    FRI
Tuesday, July 29, 2014 | 10:00 a.m. – 12:00 p.m.
Is Medicare's future secure? The 2014 Trustees Report

Please join AEI as the chief actuary for Medicare summarizes the report’s results, followed by a panel discussion of what those spending trends are likely to mean for seniors, taxpayers, the health industry, and federal policy.

Friday, August 01, 2014 | 10:30 a.m. – 12:00 p.m.
Watergate revisited: The reforms and the reality, 40 years later

Please join us as four of Washington’s most distinguished political observers will revisit the Watergate hearings and discuss reforms that followed.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.

Don't Miss...